[
    [
        {
            "time": "2018-09-06",
            "original_text": "【太平洋证券今日早读】医药行业深度报告|智飞生物、隆基股份公司点评|电子、计算机行业追踪20180906",
            "features": {
                "keywords": [
                    "医药行业",
                    "智飞生物",
                    "隆基股份",
                    "电子",
                    "计算机"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "电子",
                    "计算机"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【太平洋证券今日早读】医药行业深度报告|智飞生物、隆基股份公司点评|电子、计算机行业追踪20180906",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-09-06",
            "original_text": "【医药|杜佐远团队太平洋证券】智飞生物(300122)：EC诊断报产受理，联合微卡构建最强肺结核诊疗体系",
            "features": {
                "keywords": [
                    "智飞生物",
                    "EC诊断",
                    "微卡",
                    "肺结核",
                    "诊疗体系"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药|杜佐远团队太平洋证券】智飞生物(300122)：EC诊断报产受理，联合微卡构建最强肺结核诊疗体系",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]